Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 3/2020

01-09-2020 | Insulins | Original Article

BDNF is obverse to oxidative stress (adenosine deaminase and nitric oxide) in type II diabetes mellitus

Authors: Kakara Divya, Ramesh Malothu, E. Laxmi Narayana

Published in: International Journal of Diabetes in Developing Countries | Issue 3/2020

Login to get access

Abstract

Aim

The relational analysis of adenosine deaminase (ADA), nitric oxide (NO), BDNF (brain-derived neurotrophic factor), and TP (total protein) is accomplished by comparing these parameters with glucose levels of healthy and type II diabetes mellitus people. Type 2 diabetes (T2DM) is associated with impairment in many domains of cognitive function which may result from reduced BDNF. ADA is an important enzyme that plays a relevant role in purine and DNA metabolism, immune responses, and peptidase activity and for modulating the bioactivity of insulin. Nitric oxide is associated with loss of normal cellular function and increases the generation of nitric oxide synthetase products like nitroxyl (NO-), peroxynitrite (OONO-), and S-nitrosothiol (RSNO).

Method

In our study, a group of one hundred adult patients of either sex who had a history of not less than 6 years of diabetes mellitus and an equal number of healthy non-diabetics was selected as controls, respectively.

Results

The results of the parameters were analyzed using the SISA software and the correlation between the parameters was retrieved and represented graphically. A significant increase in adenosine deaminase activity and nitric oxide levels was observed in diabetic subjects when compared with that in controls. A significant decrease in total protein concentration and BDNF was observed in diabetic subjects when compared with that in controls. The results suggest that the increase in the glucose level has contributed to an increase in the inflammation factor ADA and oxidative stress factor NO and decrease in the total proteins especially BDNF, a neuron sentinel.
Literature
2.
go back to reference Ogurtsova K, Da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for prevalence of diabetes mellitus for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. Ogurtsova K, Da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for prevalence of diabetes mellitus for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.
3.
go back to reference Prakash MS, Chennaiah S, Murthy YS, Anjaiah E, Rao SA, Suresh C. Altered adenosine deaminase activity in type 2 diabetes mellitus. Age. 2006;43(6.2):44–6. Prakash MS, Chennaiah S, Murthy YS, Anjaiah E, Rao SA, Suresh C. Altered adenosine deaminase activity in type 2 diabetes mellitus. Age. 2006;43(6.2):44–6.
4.
go back to reference Kangralkar VA, Patil SD, Bandivadekar RM. Oxidative stress and diabetes: a review. Int J Pharm Appl. 2010;1(1):38–45. Kangralkar VA, Patil SD, Bandivadekar RM. Oxidative stress and diabetes: a review. Int J Pharm Appl. 2010;1(1):38–45.
5.
go back to reference Tyler WJ, Alonso M, Bramham CR, Pozzo Miller LD. From acquisition to consolidation: on the role of brain derived neurotrophic factor (BDNF) signaling in hippo-campal dependent learning. Learning Memory. 2002;9(5):224–37.PubMedCrossRef Tyler WJ, Alonso M, Bramham CR, Pozzo Miller LD. From acquisition to consolidation: on the role of brain derived neurotrophic factor (BDNF) signaling in hippo-campal dependent learning. Learning Memory. 2002;9(5):224–37.PubMedCrossRef
6.
go back to reference Graves DB, Bauer G. Key roles of reactive oxygen (ROS) and nitrogen species (RNS). In: Comprehensive Clinical Plasma Medicine. Cham: Springer; 2018. p. 71–82.CrossRef Graves DB, Bauer G. Key roles of reactive oxygen (ROS) and nitrogen species (RNS). In: Comprehensive Clinical Plasma Medicine. Cham: Springer; 2018. p. 71–82.CrossRef
7.
go back to reference Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, et al. Brain-derived neurotrophic factor (BDNF) and type II diabetes. Diabetologia. 2007;50(2):431–8. Krabbe KS, Nielsen AR, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C, et al. Brain-derived neurotrophic factor (BDNF) and type II diabetes. Diabetologia. 2007;50(2):431–8.
8.
go back to reference Cotman CW. The role of neuro-trophins in brain aging: a perspective in honor of Regino Perez polo. Neurochem Res. 2005;30(6–7):877–81.PubMedCrossRef Cotman CW. The role of neuro-trophins in brain aging: a perspective in honor of Regino Perez polo. Neurochem Res. 2005;30(6–7):877–81.PubMedCrossRef
9.
go back to reference Allen KV, Frier BM, Strachan MW. The relationship between type II diabetes mellitus and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol. 2004;490(1–3):169–75.PubMedCrossRef Allen KV, Frier BM, Strachan MW. The relationship between type II diabetes mellitus and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol. 2004;490(1–3):169–75.PubMedCrossRef
10.
go back to reference Donath MY, Shoelson SE. Type II diabetes mellitus as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98.PubMedCrossRef Donath MY, Shoelson SE. Type II diabetes mellitus as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98.PubMedCrossRef
11.
go back to reference Hoshino T, Yamada K, Masuoka K, Tsuboi I, Itoh K, Nonaka K, et al. Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res Clin Pract. 1994;25(2):97–102. Hoshino T, Yamada K, Masuoka K, Tsuboi I, Itoh K, Nonaka K, et al. Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res Clin Pract. 1994;25(2):97–102.
12.
go back to reference Stentz FB, Kitabchi AE. Activated T lymphocytes in type 2 diabetes: implications from in vitro studies. Curr Drug Targets. 2003;4(6):493–503.PubMedCrossRef Stentz FB, Kitabchi AE. Activated T lymphocytes in type 2 diabetes: implications from in vitro studies. Curr Drug Targets. 2003;4(6):493–503.PubMedCrossRef
13.
go back to reference Aruna S, Suchitra MM, Suresh V. Adenosine deaminase (ADA) activity in type II diabetes mellitus. J Clin Sci Res. 2017;6(4):254.CrossRef Aruna S, Suchitra MM, Suresh V. Adenosine deaminase (ADA) activity in type II diabetes mellitus. J Clin Sci Res. 2017;6(4):254.CrossRef
14.
go back to reference Kurtul N, Pence S, Akarsu E, Kocoglu H, Aksoy Y, Aksoy H. Adenosine deaminase activity in the serum of type 2 diabetic patients. Acta Medica-Hradec Kralove. 2004;47(1):33–6.PubMedCrossRef Kurtul N, Pence S, Akarsu E, Kocoglu H, Aksoy Y, Aksoy H. Adenosine deaminase activity in the serum of type 2 diabetic patients. Acta Medica-Hradec Kralove. 2004;47(1):33–6.PubMedCrossRef
15.
go back to reference Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes care. 2011;34(Supplement 2):S285–90.PubMedPubMedCentralCrossRef Avogaro A, Albiero M, Menegazzo L, de Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes care. 2011;34(Supplement 2):S285–90.PubMedPubMedCentralCrossRef
16.
go back to reference Ceriello PA. Oxidative stress and diabetes associated complications. Endocrine Pract. 2006;12(Supplement 1):60–2.CrossRef Ceriello PA. Oxidative stress and diabetes associated complications. Endocrine Pract. 2006;12(Supplement 1):60–2.CrossRef
17.
go back to reference Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006;22(6):423–36.PubMedCrossRef Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006;22(6):423–36.PubMedCrossRef
18.
19.
go back to reference Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin- phenol reagent. J Biol Chem. 1951;193(1):265–75.PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin- phenol reagent. J Biol Chem. 1951;193(1):265–75.PubMed
20.
go back to reference Ibrahim MY, Abdalla MA. Effects of Alloxan induced diabetes on blood metabolites and serum minerals and hormones in rabbit (Lepus cuniculus) in relation to starch supplementation and season. Adv Biol Res. 2011;5(1):45–58. Ibrahim MY, Abdalla MA. Effects of Alloxan induced diabetes on blood metabolites and serum minerals and hormones in rabbit (Lepus cuniculus) in relation to starch supplementation and season. Adv Biol Res. 2011;5(1):45–58.
21.
go back to reference Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, et al. BDNF is essential to promote persistence of long term memory storage. Proc Natl Acad Sci. 2008;105(7):2711–6. Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, et al. BDNF is essential to promote persistence of long term memory storage. Proc Natl Acad Sci. 2008;105(7):2711–6.
22.
go back to reference Tapia Arancibia L, Rage F, Givalois L, Arancibia S. Physiology of (BDNF) brain derived neurotrophic factor: focus on hypothalamic function. Front Neuroendocrinol. 2004;25(2):77–107.PubMedCrossRef Tapia Arancibia L, Rage F, Givalois L, Arancibia S. Physiology of (BDNF) brain derived neurotrophic factor: focus on hypothalamic function. Front Neuroendocrinol. 2004;25(2):77–107.PubMedCrossRef
23.
go back to reference Geroldi D, Minoretti P, Emanuele E. Brain-derived neurotrophic factor (BDNF) and the metabolic syndrome: more than just a hypothesis. Medical hypothesis. 2006;1(67):195–6.CrossRef Geroldi D, Minoretti P, Emanuele E. Brain-derived neurotrophic factor (BDNF) and the metabolic syndrome: more than just a hypothesis. Medical hypothesis. 2006;1(67):195–6.CrossRef
24.
go back to reference Lebrun B, Bariohay B, Moyse E, Jean A. Brain-derived neurotrophic factor and food intake regulation: a mini review. Auton Neurosci. 2006;126:30–8.PubMedCrossRef Lebrun B, Bariohay B, Moyse E, Jean A. Brain-derived neurotrophic factor and food intake regulation: a mini review. Auton Neurosci. 2006;126:30–8.PubMedCrossRef
25.
go back to reference Yamanaka M, Itakura Y, Inoue T, Tsuchida A, Nakagawa T, Noguchi H, et al. Protective effect of brain-derived neurotrophic factor (BDNF) on pancreatic- islets in obese diabetic mice. Metabolism. 2006;55(10):1286–92. Yamanaka M, Itakura Y, Inoue T, Tsuchida A, Nakagawa T, Noguchi H, et al. Protective effect of brain-derived neurotrophic factor (BDNF) on pancreatic- islets in obese diabetic mice. Metabolism. 2006;55(10):1286–92.
26.
go back to reference Unger TJ, Calderon GA, Bradley LC, Sena-Esteves M, Rios M. Selective deletion of BDNF in the ventro-medial and dorso-medial hypothalamus of adult mice, results in hyper-phagic behavior and obesity. J Neurosci. 2007;27(52):14265–74.PubMedPubMedCentralCrossRef Unger TJ, Calderon GA, Bradley LC, Sena-Esteves M, Rios M. Selective deletion of BDNF in the ventro-medial and dorso-medial hypothalamus of adult mice, results in hyper-phagic behavior and obesity. J Neurosci. 2007;27(52):14265–74.PubMedPubMedCentralCrossRef
27.
go back to reference Layman DK, Clifton P, Gannon MC, Krauss RM, Nuttall FQ. Protein in optimal health: heart disease and type 2 diabetes. Am J Clin Nutr. 2008;87(5):1571S–5S.PubMedCrossRef Layman DK, Clifton P, Gannon MC, Krauss RM, Nuttall FQ. Protein in optimal health: heart disease and type 2 diabetes. Am J Clin Nutr. 2008;87(5):1571S–5S.PubMedCrossRef
28.
go back to reference Powers MA. Hand-book of diabetes medical nutrition theraphy: Jones & Bartlett Learning; 1996. Powers MA. Hand-book of diabetes medical nutrition theraphy: Jones & Bartlett Learning; 1996.
29.
go back to reference Franz MJ. Protein controversies in diabetes mellitus. Diabetes Spectrum. 2000;13(3):132. Franz MJ. Protein controversies in diabetes mellitus. Diabetes Spectrum. 2000;13(3):132.
30.
go back to reference Giusti G. Adenosine Deaminase (ADA). In: Methods of enzymatic analysis (second edition), vol. 2; 1974. p. 1092–9.CrossRef Giusti G. Adenosine Deaminase (ADA). In: Methods of enzymatic analysis (second edition), vol. 2; 1974. p. 1092–9.CrossRef
31.
go back to reference Sun J, Zhang X, Broderick M, Fein H. Measurement of nitric oxide (NO) production in biological systems by using Griess- reaction assay. Sensors. 2003;3(8):276–84.CrossRef Sun J, Zhang X, Broderick M, Fein H. Measurement of nitric oxide (NO) production in biological systems by using Griess- reaction assay. Sensors. 2003;3(8):276–84.CrossRef
32.
go back to reference Stam NJ, Spits H, Ploegh HL. Monoclonal antibodies (Mab) raised against denatured HLA B locus heavy chains permit biochemical characterization of certain HLA C locus products. J Immunol. 1986;137(7):2299–306.PubMed Stam NJ, Spits H, Ploegh HL. Monoclonal antibodies (Mab) raised against denatured HLA B locus heavy chains permit biochemical characterization of certain HLA C locus products. J Immunol. 1986;137(7):2299–306.PubMed
33.
go back to reference Loghmani ES. Nutrition therapy for overweight children and adolescents with type 2 diabetes. Current diabetes reports. 2005;5(5):385–90.PubMedCrossRef Loghmani ES. Nutrition therapy for overweight children and adolescents with type 2 diabetes. Current diabetes reports. 2005;5(5):385–90.PubMedCrossRef
34.
go back to reference Niraula A, Thapa S, Kunwar S, Lamsal M, Baral N, Maskey R. Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role? BMC Endocr Disord. 2018;18(1):58.PubMedPubMedCentralCrossRef Niraula A, Thapa S, Kunwar S, Lamsal M, Baral N, Maskey R. Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role? BMC Endocr Disord. 2018;18(1):58.PubMedPubMedCentralCrossRef
35.
go back to reference Ghosh A, Sherpa ML, Yazum Bhutia RP, Dahal S. Serum nitric oxide status in patients with type 2 diabetes mellitus in Sikkim. International Journal of Applied and Basic Medical Research. 2011;1(1):31–5.PubMedPubMedCentralCrossRef Ghosh A, Sherpa ML, Yazum Bhutia RP, Dahal S. Serum nitric oxide status in patients with type 2 diabetes mellitus in Sikkim. International Journal of Applied and Basic Medical Research. 2011;1(1):31–5.PubMedPubMedCentralCrossRef
36.
go back to reference Scallan JP, Hill MA, Davis MJ. Lymphatic vascular integrity is disrupted in type 2 diabetes mellitus due to impaired nitric oxide signaling. Cardiovasc Res. 2015;107(1):89–97.PubMedPubMedCentralCrossRef Scallan JP, Hill MA, Davis MJ. Lymphatic vascular integrity is disrupted in type 2 diabetes mellitus due to impaired nitric oxide signaling. Cardiovasc Res. 2015;107(1):89–97.PubMedPubMedCentralCrossRef
37.
go back to reference McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35(8):771-776. McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992;35(8):771-776.
38.
go back to reference Abu-Lebdeh HS, Nair KS. Protein metabolism in diabetes mellitus. Baillieres Clin Endocrinol Metab. 1996;10(4):589–601.PubMedCrossRef Abu-Lebdeh HS, Nair KS. Protein metabolism in diabetes mellitus. Baillieres Clin Endocrinol Metab. 1996;10(4):589–601.PubMedCrossRef
41.
go back to reference Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Taiji M. Brain-derived Neurotrophic- factor (BDNF) prevents the development of diabetes mellitus in pre-diabetic mice. Biomed Res. 2008;29(3):147–53.PubMedCrossRef Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Taiji M. Brain-derived Neurotrophic- factor (BDNF) prevents the development of diabetes mellitus in pre-diabetic mice. Biomed Res. 2008;29(3):147–53.PubMedCrossRef
42.
go back to reference Ono M, Ichihara J, Nonomura T, Itakura Y, Taiji M, Nakayama C, et al. Brain-derived neurotrophic- factor reduces the blood glucose level in obese diabetic mice but not in normal mice. Biochem Biophys Res Commun. 1997;238(2):633–7. Ono M, Ichihara J, Nonomura T, Itakura Y, Taiji M, Nakayama C, et al. Brain-derived neurotrophic- factor reduces the blood glucose level in obese diabetic mice but not in normal mice. Biochem Biophys Res Commun. 1997;238(2):633–7.
43.
go back to reference Awad N, Gagnon M, Messier C. The relation-ship between impaired glucose tolerance, type II diabetes mellitus and cognitive function. J Clin Exp Neuropsychol. 2004;26(8):1044–80.PubMedCrossRef Awad N, Gagnon M, Messier C. The relation-ship between impaired glucose tolerance, type II diabetes mellitus and cognitive function. J Clin Exp Neuropsychol. 2004;26(8):1044–80.PubMedCrossRef
Metadata
Title
BDNF is obverse to oxidative stress (adenosine deaminase and nitric oxide) in type II diabetes mellitus
Authors
Kakara Divya
Ramesh Malothu
E. Laxmi Narayana
Publication date
01-09-2020
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 3/2020
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-019-00793-4

Other articles of this Issue 3/2020

International Journal of Diabetes in Developing Countries 3/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.